ATE413890T1 - Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort - Google Patents

Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort

Info

Publication number
ATE413890T1
ATE413890T1 AT05791035T AT05791035T ATE413890T1 AT E413890 T1 ATE413890 T1 AT E413890T1 AT 05791035 T AT05791035 T AT 05791035T AT 05791035 T AT05791035 T AT 05791035T AT E413890 T1 ATE413890 T1 AT E413890T1
Authority
AT
Austria
Prior art keywords
subject
vaccine
hormone
immune response
enhances
Prior art date
Application number
AT05791035T
Other languages
English (en)
Inventor
Ruxandra Draghia-Akli
Patrica Brown
Amir Khan
William Davis
Original Assignee
Advisys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advisys Inc filed Critical Advisys Inc
Application granted granted Critical
Publication of ATE413890T1 publication Critical patent/ATE413890T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05791035T 2004-07-23 2005-07-21 Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort ATE413890T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59073904P 2004-07-23 2004-07-23

Publications (1)

Publication Number Publication Date
ATE413890T1 true ATE413890T1 (de) 2008-11-15

Family

ID=35717476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05791035T ATE413890T1 (de) 2004-07-23 2005-07-21 Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort

Country Status (10)

Country Link
US (1) US20060025368A1 (de)
EP (1) EP1809336B1 (de)
JP (1) JP2008507537A (de)
CN (1) CN101027081A (de)
AT (1) ATE413890T1 (de)
AU (1) AU2005269724B2 (de)
DE (1) DE602005011041D1 (de)
MX (1) MX2007000893A (de)
NZ (1) NZ553274A (de)
WO (1) WO2006014737A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846720B2 (en) * 2005-01-26 2010-12-07 Vgx Pharmaceuticals, Inc. Optimized high yield synthetic plasmids
CN101778643B (zh) * 2007-05-21 2013-05-22 塞莱克蒂斯股份有限公司 用于向哺乳动物皮肤输送多核苷酸的方法和装置
KR101708277B1 (ko) * 2008-05-28 2017-02-20 이노비오 파마수티컬즈, 인크. 천연두 ｄｎａ 백신 및 면역 반응을 유도하는 상기 백신 내에 항원
CN108707589B (zh) * 2018-06-07 2021-11-26 西南民族大学 一种牛病毒性腹泻病毒SMU-Z6/1a/SC/2016分离株及其应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228156A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4228158A (en) * 1979-03-30 1980-10-14 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223019A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4226857A (en) * 1979-03-30 1980-10-07 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4224316A (en) * 1979-03-30 1980-09-23 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223021A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4223020A (en) * 1979-03-30 1980-09-16 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4410512A (en) * 1981-12-28 1983-10-18 Beckman Instruments, Inc. Combinations having synergistic pituitary growth hormone releasing activity
US5134120A (en) * 1984-08-03 1992-07-28 Cornell Research Foundation, Inc. Use of growth hormone to enhance porcine weight gain
US5036045A (en) * 1985-09-12 1991-07-30 The University Of Virginia Alumni Patents Foundation Method for increasing growth hormone secretion
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
US4833166A (en) * 1987-05-01 1989-05-23 Grosvenor Clark E Growth hormone releasing hormone complementary peptides
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
USRE33699E (en) * 1987-07-09 1991-09-24 International Minerals & Chemical Corp. Growth hormone-releasing factor analogs
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
US5023322A (en) * 1988-08-31 1991-06-11 Mta Kutatas-Es Szervezetelemzo Intezete Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5134210A (en) * 1989-07-27 1992-07-28 Edwards Bill R Acrylic resin composition
US5137872A (en) * 1989-09-18 1992-08-11 Pitman-Moore, Inc. Growth hormone-releasing factor analogs
ZA914983B (en) * 1990-06-29 1992-03-25 Hoffmann La Roche His-grf-analogs
US5486505A (en) * 1990-07-24 1996-01-23 Polygen Holding Corporation Polypeptide compounds having growth hormone releasing activity
WO1992018531A1 (en) * 1991-04-09 1992-10-29 F. Hoffmann-La Roche Ag Growth hormone releasing factor analogs
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
US5298422A (en) * 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
US5439440A (en) * 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US5702359A (en) * 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US5792747A (en) * 1995-01-24 1998-08-11 The Administrators Of The Tulane Educational Fund Highly potent agonists of growth hormone releasing hormone
WO1996032126A1 (en) * 1995-04-14 1996-10-17 The Administrators Of The Tulane Educational Fund Analogs of growth hormone-releasing factor
CA2289040A1 (en) * 1997-05-01 1998-11-05 Protechtion Unlimited, Inc. Nerve growth factor as a vaccine adjuvant
CA2303702A1 (en) * 1999-04-12 2000-10-12 Pfizer Products Inc. Growth hormone and growth hormone releasing hormone compositions
US20020058039A1 (en) * 2000-04-27 2002-05-16 Coyne Michael J. Method of measuring the duration of adequate immune memory in companion animals
WO2003047602A1 (en) * 2001-12-07 2003-06-12 Intercell Ag Immunostimulatory oligodeoxynucleotides
US7241744B2 (en) * 2001-12-11 2007-07-10 Baylor College Of Medicine Treating anemia in subjects by administration of plasmids encoding growth hormone releasing hormone
AU2003273142A1 (en) * 2002-05-28 2003-12-12 Advisys, Inc. Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system

Also Published As

Publication number Publication date
US20060025368A1 (en) 2006-02-02
CN101027081A (zh) 2007-08-29
AU2005269724A1 (en) 2006-02-09
AU2005269724B2 (en) 2011-03-10
EP1809336A2 (de) 2007-07-25
MX2007000893A (es) 2007-04-18
WO2006014737A2 (en) 2006-02-09
DE602005011041D1 (de) 2008-12-24
NZ553274A (en) 2010-02-26
JP2008507537A (ja) 2008-03-13
WO2006014737A3 (en) 2006-05-11
EP1809336B1 (de) 2008-11-12

Similar Documents

Publication Publication Date Title
Heppell et al. Application of DNA vaccine technology to aquaculture
RU2010149495A (ru) Новые адъювантные композиции
AR061930A1 (es) Mimeticuerpos de glp-1 humanos, composiciones, metodos y usos
WO2007022151A3 (en) Immunization of avians by administration of non-replicating vectored vaccines
RU2008105348A (ru) Вакцина на основе lawsonia и способы ее применения
WO2006113622A3 (en) Direct vaccination of the bone marrow
UA110328C2 (en) Recombinant vaccine based on avian paramixoviruses and method for its preparation and administration
AR036125A1 (es) Vacuna de mycoplasma bovis metodos para reducir la neumonia en animales; procedimiento de preparacion de dicha vacuna y kit
US20160120628A1 (en) Fluttering ear tag for bovine vaccination
ATE413890T1 (de) Wachstumshormon-freisetzendes hormon verstärkt die vakzin-induzierte immunantwort
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
Mansoor et al. Intranasal delivery of nanoparticles encapsulating BPI3V proteins induces an early humoral immune response in mice
WO2002081621A3 (fr) Vaccin contre le virus de la fievre du nil
JP6802790B2 (ja) アジュバント組成物及び関連方法
JP2017537106A5 (de)
RU2010143584A (ru) Вакцина для защиты от haemophilus parasuis серотипа 4 у поросят
TWI378144B (en) Recombinant plasmic containing multicopy cpg motifs and transformant thereof for applying on dna adjuvant in avian vaccines
Ebrahimi DNA Vaccine and its Importance in Veterinary
JP2012533557A (ja) 舌上ワクチン及びアプリケーター
UA96923C2 (ru) Вакцина на основе lawsonia и способы ее применения
Vos et al. Maternal immunity against rabies in raccoon dogs
DK1337553T3 (da) Nucleinsyrevaccine omfattende et fusionsprotein inklusiv en adjuvanssekvens fra et vegetabilsk viralt kappeprotein
FR2804026B1 (fr) Vaccination contre l'herpesvirose canine et vaccins
Schrupp et al. Effect of Vaccinating Pre-Weaned Dairy Calves on Cell Mediated Immune Function
Biuk-Rudan et al. Specific and non-specific protection of pigs exposed to contact infection with Aujeszky's disease virus (ADV)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties